1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow AZD2461: new trials by email Literature Review of AZD2461 trials Research Report on AZD2461
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label, Dose-Escalation Study of AZD2461 AZD2461 - Refractory Solid Tumors, Cancer Tumor | Phase 1 | Completed | AstraZeneca | 75 | 2010-11-01 | 2012-06-06 |
Neoplasms (1)
AstraZeneca (1)
United States (1)
Andrew Hughes, MA, MB, ChB, PhD, P (1) · Dr. Jeffrey Infante, MD (1)